FY2026 Earnings Estimate for Calumet Issued By HC Wainwright

Calumet, Inc. (NASDAQ:CLMT) – Research analysts at HC Wainwright increased their FY2026 earnings per share (EPS) estimates for Calumet in a note issued to investors on Wednesday, September 2nd. HC Wainwright analyst A. Dayal now anticipates that the oil and gas company will post earnings of $0.17 per share for the year, up from their previous forecast of $0.12. HC Wainwright currently has a “Buy” rating and a $75.00 target price on the stock. The consensus estimate for Calumet’s current full-year earnings is $0.46 per share. HC Wainwright also issued estimates for Calumet’s FY2027 earnings at $1.11 EPS.

Calumet (NASDAQ:CLMT) last released its quarterly earnings data on Friday, August 7th. The oil and gas company reported ($1.09) EPS for the quarter, missing the consensus estimate of $0.07 by ($1.16). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.12 billion. During the same quarter in the previous year, the business earned ($1.70) earnings per share. Calumet’s revenue was up 40.8% compared to the same quarter last year.

CLMT has been the topic of a number of other research reports. TD Cowen raised their price target on shares of Calumet from $34.00 to $40.00 and gave the company a “hold” rating in a report on Wednesday, August 12th. Citigroup reiterated a “buy” rating on shares of Calumet in a research note on Monday, August 10th. UBS Group boosted their price objective on shares of Calumet from $26.00 to $47.00 and gave the company a “neutral” rating in a report on Tuesday, August 25th. The Goldman Sachs Group increased their price objective on shares of Calumet from $40.00 to $45.00 and gave the company a “neutral” rating in a research report on Tuesday, August 18th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Calumet in a report on Friday, August 7th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $51.75.

Calumet Stock Performance

Shares of NASDAQ:CLMT opened at $53.50 on Friday. Calumet has a fifty-two week low of $16.56 and a fifty-two week high of $54.70. The business has a 50-day simple moving average of $43.40 and a two-hundred day simple moving average of $36.09. The firm has a market cap of $4.70 billion, a price-to-earnings ratio of -34.52 and a beta of 0.72.

Institutional Investors Weigh In On Calumet

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Fifth Third Bancorp lifted its stake in shares of Calumet by 11.3% in the 2nd quarter. Fifth Third Bancorp now owns 3,407 shares of the oil and gas company’s stock worth $123,000 after purchasing an additional 346 shares during the period. Covestor Ltd boosted its holdings in shares of Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after buying an additional 492 shares during the last quarter. Caldwell Sutter Capital Inc. grew its position in Calumet by 2.7% during the second quarter. Caldwell Sutter Capital Inc. now owns 20,000 shares of the oil and gas company’s stock valued at $720,000 after buying an additional 517 shares during the period. ProShare Advisors LLC grew its position in Calumet by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 12,613 shares of the oil and gas company’s stock valued at $251,000 after buying an additional 817 shares during the period. Finally, Aster Capital Management DIFC Ltd grew its position in Calumet by 294.7% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after buying an additional 1,229 shares during the period. Hedge funds and other institutional investors own 34.41% of the company’s stock.

Insiders Place Their Bets

In other Calumet news, Director Daniel Sajkowski sold 4,240 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the transaction, the director directly owned 77,718 shares of the company’s stock, valued at approximately $2,810,282.88. This trade represents a 5.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.15% of the company’s stock.

Calumet News Roundup

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised its price target for Calumet to $75 from $60 and reiterated a “Buy” rating, implying substantial potential upside based on the referenced share price. The firm also increased its 2026 EPS forecasts to $0.62 for the third quarter and $0.24 for the fourth quarter, from $0.60 and $0.22, respectively. HC Wainwright estimates and price target
• Positive Sentiment: Calumet said recent U.S. EPA small-refinery exemptions are expected to reduce its Renewable Identification Number, or RIN, liability by approximately $170 million. The potential savings could improve cash flow and profitability by lowering the company’s renewable-fuel compliance costs. Calumet EPA exemption update
• Positive Sentiment: Calumet’s Montana Renewables business is adjusting its expansion plans to increase sustainable aviation fuel production capacity, with reports indicating a potential target of 200 million gallons annually. Greater SAF capacity could support longer-term growth in renewable fuels. Montana Renewables SAF expansion
• Neutral Sentiment: Calumet plans to participate in the H.C. Wainwright conference, which may provide management an opportunity to discuss operations, the EPA exemptions and its renewable-fuels strategy with investors. Calumet conference announcement
• Neutral Sentiment: Analyst coverage remains mixed overall, with the broader analyst consensus listed as “Hold,” despite H.C. Wainwright’s more bullish outlook.
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. The announcement does not establish wrongdoing, but securities investigations can create legal, reputational and disclosure-related uncertainty. Pomerantz investor investigation

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.